Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of novel hit compounds as potential HDAC1 inhibitors: The case of ligand- and structure-based virtual screening
Hajar Sirous, Giuseppe Campiani, Vincenzo Calderone, et al.
Computers in Biology and Medicine (2021) Vol. 137, pp. 104808-104808
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article
Nardin Wagih, Islam M. Abdel-Rahman, Nawal El‐Koussi, et al.
RSC Advances (2025) Vol. 15, Iss. 2, pp. 966-1010
Open Access | Times Cited: 2
Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions
Basharat Ahmad, Aamir Saeed, Ahmed Al-Amery, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 444-444
Open Access | Times Cited: 5
The Integration of Molecular Docking and Machine Learning in Drug Discovery for Neurological Disorders
Aditya Singh, Shubhrat Maheshwari, Jigna B. Prajapati, et al.
(2025), pp. 349-374
Closed Access
Screening of Phytocompounds for Identification of Prospective Histone Deacetylase 1 (HDAC1) Inhibitor: An In Silico Molecular Docking, Molecular Dynamics Simulation, and MM-GBSA Approach
Kaushik Kumar Bharadwaj, Iqrar Ahmad, Siddhartha Pati, et al.
Applied Biochemistry and Biotechnology (2023) Vol. 196, Iss. 7, pp. 3747-3764
Closed Access | Times Cited: 8
Virtual screening and activity evaluation of human uric acid transporter 1 (hURAT1) inhibitors
Yacong Yang, Yu Hu, Fengli Yao, et al.
RSC Advances (2023) Vol. 13, Iss. 6, pp. 3474-3486
Open Access | Times Cited: 7
Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies
Preeti Patel, Sushant K. Shrivastava, Piyoosh Sharma, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 1, pp. 362-383
Closed Access | Times Cited: 7
In the quest for histone deacetylase inhibitors: current trends in the application of multilayered computational methods
Abdullahi İbrahim Uba, Gökhan Zengin
Amino Acids (2023) Vol. 55, Iss. 12, pp. 1709-1726
Closed Access | Times Cited: 7
Design of 2-amino-6-methyl-pyrimidine benzoic acids as ATP competitive casein kinase-2 (CK2) inhibitors using structure- and fragment-based design, docking and molecular dynamic simulation studies
Saumya Patel, Saumya Patel, Kartik Tulsian, et al.
SAR and QSAR in environmental research (2023) Vol. 34, Iss. 3, pp. 211-230
Open Access | Times Cited: 6
Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations
Behnaz Yazdani, Hajar Sirous, Francisco J. Enguita, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1203-1224
Closed Access | Times Cited: 5
Synthetic derivatives of natural cinnamic acids as potential anti‐colorectal cancer agents
Federica Falbo, Sandra Gemma, Adrian Koch, et al.
Chemical Biology & Drug Design (2023) Vol. 103, Iss. 1
Open Access | Times Cited: 5
Development of New Inhibitors of HDAC1–3 Enzymes Aided by In Silico Design Strategies
Narges Cheshmazar, Salar Hemmati, Maryam Hamzeh‐Mivehroud, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 10, pp. 2387-2397
Closed Access | Times Cited: 8
In-silico bioprospecting of secondary metabolites from endophytic Streptomyces spp. against Magnaporthe oryzae, a cereal killer fungus
Ajitha Antony, V. Shanthi, K. Ramanathan
3 Biotech (2023) Vol. 14, Iss. 1
Closed Access | Times Cited: 4
Based on Virtual Screening and Simulation Exploring the Mechanism of Plant-Derived Compounds with PINK1 to Postherpetic Neuralgia
Wenjing Guo, Bo Zhang, Minchen Liu, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 11, pp. 9184-9203
Open Access | Times Cited: 1
Cupressus sempervirens L. flavonoids as potent inhibitors to xanthine oxidase: in vitro, molecular docking, ADMET and PASS studies
Abderahmane Linani, Talia Serseg, Khedidja Benarous, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 15, pp. 7055-7068
Closed Access | Times Cited: 6
A quantitative structural analysis of AR-42 derivatives as HDAC1 inhibitors for the identification of promising structural contributors
Ramendra Kundu, Suvankar Banerjee, Sandip Kumar Baidya, et al.
SAR and QSAR in environmental research (2022) Vol. 33, Iss. 11, pp. 861-883
Closed Access | Times Cited: 6
Disruption of Irisin Dimerization by FDA-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes
Lorenzo Flori, Simone Brogi, Hajar Sirous, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7578-7578
Open Access | Times Cited: 2
Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a)
Abhisek Jana, Rahul Naga, Sougata Saha, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 7, pp. 3535-3562
Closed Access | Times Cited: 2
Identification of novel and potent dual-targeting HDAC1/SPOP inhibitors using structure-based virtual screening, molecular dynamics simulation and evaluation of in vitro and in vivo antitumor activity
Yingxue Yang, Shutong Chen, Qinghua Wang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Artificial Intelligence in Translational Medicine
Simone Brogi, Vincenzo Calderone
International Journal of Translational Medicine (2021) Vol. 1, Iss. 3, pp. 223-285
Open Access | Times Cited: 4
Molecular docking, molecular dynamics simulation, and MM/PBSA analysis of ginger phytocompounds as a potential inhibitor of AcrB for treating multidrug-resistant Klebsiella pneumoniae infections
Maheswata Sahoo, Dibyajyoti Uttameswar Behera, Mahendra Gaur, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-17
Closed Access
Virtual screening and biological evaluation of natural products as urate transporter 1 (URAT1) inhibitors
Chunying Du, Hua Yin, Aowei Xie, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access
Computational Screening of Repurposed Drugs for HMG-CoA Synthase 2 in Alzheimer’s Disease
Anas Shamsi, Mohammad Furkan, Mohd Shahnawaz Khan, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 2, pp. 475-485
Closed Access
Pharmacophore modeling, 3D-QSAR, and MD simulation-based overture for the discovery of new potential HDAC1 inhibitors
Goverdhan Lanka, Suvankar Banerjee, Sanjeev Regula, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-24
Closed Access
Synthesis, Biological Evaluation and in Silico Studies of Novel Urea/Thiourea Derivatives of Lenalidomide
Fatih Tok, Burçin İrem Abas, Faika Başoğlu, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 12
Closed Access
Discovery of novel pyrrolo[2,3-d]pyrimidine derivatives as anticancer agents: virtual screening and molecular dynamic studies
Sunny Dhiman, Swati Gupta, Sushil K. Kashaw, et al.
SAR and QSAR in environmental research (2024), pp. 1-33
Closed Access
Page 1 - Next Page

Scroll to top